Professor Christo Muller holds a PhD in Medical Sciences. He is currently Chief Specialist Scientist at the SAMRC’s Biomedical Research and Innovation Platform (BRIP).

Prof Muller focuses his research on the potential role of phenolic compounds in the prevention and treatment of metabolic conditions such as insulin resistance, dysbiosis, obesity and type 2 diabetes. He is also involved with a proteomics study to identify early markers for type 2 diabetes. These markers are currently being tested in human subjects. He has 2 International patents (USA and Europe) for the prevention of diabetes and has authored and co-authored 81 peer–reviewed articles and two book chapters. He has graduated 5 MSc, 3 PhD and supervised 2 postdoctoral fellows. Currently he is supervising 3 PhD’s and 4 MSc students and acts as a reviewer for many international journals.

His research focus areas include, Metabolic disease (pathophysiology, prevention and treatment), phytotherapeutics and early detection of type 2 diabetes.